163 related articles for article (PubMed ID: 5557740)
1. [Studies on absorption, elimination and anti-arrhythmic serum concentrations of diphenylhydantoin (Antisacer) in digitalized heart patients].
Weber-Eggenberger S; Kaufmann G
Z Kreislaufforsch; 1971 May; 60(5):420-32. PubMed ID: 5557740
[No Abstract] [Full Text] [Related]
2. [Experience with diphenylhydantoin (antisacer) in the management of cardiac arrhythmias].
Kaufmann G; Hauser K
Schweiz Med Wochenschr; 1968 Aug; 98(33):1223-6. PubMed ID: 5682098
[No Abstract] [Full Text] [Related]
3. [Hemodynamic changes due to diphenylhydantoin in digitalized heart patients].
Kaufmann G; Weber-Eggenberger S
Schweiz Med Wochenschr; 1970 Dec; 100(50):2164-8. PubMed ID: 5526157
[No Abstract] [Full Text] [Related]
4. [Diphenylhydantoin. Clinical pharmacology. Apropos of 86 utilizations in various arrhythmias].
Chiche P; Benaim R; Chesnais F
Ann Cardiol Angeiol (Paris); 1971; 20(3):231-42. PubMed ID: 5559002
[No Abstract] [Full Text] [Related]
5. Digitalis and other cardiac glycosides.
Breckenridge AM; Orme ML
Practitioner; 1979 Oct; 223(1336):465-9. PubMed ID: 523400
[No Abstract] [Full Text] [Related]
6. [Treatment of digitalis-induced rhythm disorders of the heart with diphenylhydantoin].
Hansen HW
Med Klin; 1970 Jan; 65(3):101-4. PubMed ID: 5519046
[No Abstract] [Full Text] [Related]
7. [Does digitalis help in heart failure when heart rhythm is normal?].
Stokland O
Tidsskr Nor Laegeforen; 1984 Oct; 104(29):2038-40. PubMed ID: 6506044
[No Abstract] [Full Text] [Related]
8. [Digitalis glycosides].
Burrus O
Rev Infirm; 1987 Apr; 37(7):35-8. PubMed ID: 3647577
[No Abstract] [Full Text] [Related]
9. [Digitalis in cardiopathies].
Doherty JE
Clin Ter; 1967 Dec; 43(6):513-22. PubMed ID: 5617979
[No Abstract] [Full Text] [Related]
10. [On the use of beta-adrenergic receptor blocking agents in digitalized cardiac insufficiency].
Zamfir C; Turcu E; Marinescu B; Efanov A; Teodorescu C
Med Interna (Bucur); 1970 Sep; 22(9):1097-106. PubMed ID: 4395278
[No Abstract] [Full Text] [Related]
11. [Indications and mode of action of digitalis glycosides. A new hemisynthetic compound: formyl 16 gytoxin].
Chiche P; Derai C; Melman S; Chekler P
Therapeutique; 1970 Jan; 46(1):17-24. PubMed ID: 5437772
[No Abstract] [Full Text] [Related]
12. [Digitalis therapy].
Dalla Volta S
G Clin Med; 1987 Dec; 68(12):627-33, 635-41, 643-8 passim. PubMed ID: 3329138
[No Abstract] [Full Text] [Related]
13. [16-acetylgitoxin--a semisynthetic glycoside of digitalis purpurea].
Heuchel G; Coch H
Z Gesamte Inn Med; 1971 Feb; 26(3):89-93. PubMed ID: 5560772
[No Abstract] [Full Text] [Related]
14. [Drug therapy of heart failure, rhythm disorders and collapse in the acute phase of myocardial infarct].
Bensaid J; Penther P; Coblence B
Ann Cardiol Angeiol (Paris); 1968; 17(4):347-52. PubMed ID: 5745234
[No Abstract] [Full Text] [Related]
15. [Digitalis glycoside prescribing at a district nursing home].
Pietschmann GJ; Bär K
Z Arztl Fortbild (Jena); 1986; 80(23):991-3. PubMed ID: 3577230
[No Abstract] [Full Text] [Related]
16. The pharmacology and clinical use of digitalis.
Rasmussen S; Noble J; Fisch C
Cardiovasc Nurs; 1975; 11(1):23-8. PubMed ID: 1038351
[No Abstract] [Full Text] [Related]
17. Digitalis treatment decreases mortality and morbidity in heart failure patients. Reanalysis of digitalis treatment.
Wehrmacher WH
Cardiology; 2007; 108(3):157-8. PubMed ID: 17077627
[No Abstract] [Full Text] [Related]
18. [Cardiac therapy in acute pneumonia].
Runge M; von Wichert P
Prax Klin Pneumol; 1985 Jul; 39(7):221-5. PubMed ID: 4034487
[No Abstract] [Full Text] [Related]
19. [Diphenylhydantoin: its use in cardiology].
Acosta Varo M; Pérez de Ayala C; Mate Benito I; Ortiz Vázquez J
Rev Clin Esp; 1973 Jun; 129(5):477-86. PubMed ID: 4732992
[No Abstract] [Full Text] [Related]
20. [Digitalis: anti-arrhythmic and toxic effects].
Haslam P
Infirm Can; 1980 Mar; 22(3):20-5. PubMed ID: 6898566
[No Abstract] [Full Text] [Related]
[Next] [New Search]
